A. Fauser

Learn More
Tyrosine kinase inhibitors represent today's treatment of choice in chronic myeloid leukemia (CML). Allogeneic hematopoietic stem cell transplantation (HSCT) is regarded as salvage therapy. This prospective randomized CML-study IIIA recruited 669 patients with newly diagnosed CML between July 1997 and January 2004 from 143 centers. Of these, 427 patients(More)
Treatment of chronic myeloid leukemia (CML) has been profoundly improved by the introduction of tyrosine kinase inhibitors (TKIs). Long-term survival with imatinib is excellent with a 8-year survival rate of ∼88%. Long-term toxicity of TKI treatment, especially carcinogenicity, has become a concern. We analyzed data of the CML study IV for the development(More)
In 1978, the European disco group Boney M made history when they performed a series of ten concerts in Moscow as the guests of the Soviet government, the first Western popular music group to receive such an invitation. Yet despite breaking through the Iron Curtain, Boney M could not avoid the censorship of the Communist government. One of their biggest hits(More)
  • 1